CD8 T cells are divided into naive and memory subsets according to both function and phenotype. In HIlV-negative children, the naive subset is present at high frequencies, whereas memory cells are virtually absent. Previous studies have shown that the overall number of CD8 T cells does not decrease in HIV-infected children. In studies here, we use multiparameter flow cytometry to distinguish naive from memory CD8 T cells based on expression of CD11a, CD45RA, and CD62L. With this methodology, we show that within the CD8 T cell population, the naive subset decreases markedly (HIV + vs. HIV -, 190 vs. 370 cells/,lp; P < 0.003), and that there is a reciprocal increase in memory cells, such that the total CD8 T cell counts remained unchanged (800 vs. 860 cells/pul; P < 0.76). In addition, we show that for HIV-infected children, the naive CD8 T cell and total CD4 T cell counts correlate (k P 0.001). This correlated loss suggests that the loss of naive CD8 T cells in HIV infection may contribute to the defects in cell-mediated immunity which become progressively worse as the HIV disease progresses and CD4 counts decrease. (J. Clin. Invest. 1995.
Introduction
CD8 T cells, which provide cell-mediated immunity through both cytotoxic and suppresser mechanisms (1) , are subdivided by multiparameter flow cytometry (FACS®) into subsets according to the differential expression of surface proteins. These subsets are also functionally distinct (2, 3) . In particular, the subset that expresses the CD45RA surface marker (CD45RAhi), which is often referred to as the naive (or virgin) subset, makes a relatively poor cytokine response after T cell receptor stimulation. In contrast, the so-called memory subset, which secretes a wide variety of cytokines in response to T cell receptor stimulation, expresses CD45RO (another isoform of CD45 [reference 3]) instead of CD45RA (3, 4) .
Several reports have described changes in the CD8 T cell subsets in HIV-infected individuals. The total CD8 T cell count in blood usually increases initially and only falls late in the disease (5, 6) . Naive CD8 T cell frequencies, estimated on the basis of CD45RA expression alone, were found to decrease little (7, 8) or not at all (9) . Memory CD8 T cell frequencies, estimated on the basis of CD45RO expression ( 10, 11) , were found to increase in infected children. However, the methodology used in these studies did not definitively resolve the naive and memory subsets, since the shift from CD45RA'I to CD45RO (CD45RA-) is reversible and thus not all CD8 T cells that express the CD45RA'I (CD45RO-) phenotype are naive (12, 13) .
Recent studies have identified several other surface markers (14) that provide a better indication of the maturation from naive to memory, e.g., the increase in expression of CD1la (LFA-la) (15) and the loss of expression of CD62L (L-selectin, LECAM) (16) . Therefore, to definitively resolve the memory and naive subsets in studies presented here, we used threecolor multiparameter flow cytometry to simultaneously measure CD8, CD45RA, and either CD1la or CD62L. The results of this study unequivocally demonstrate that HIV-infected children lose a substantial fraction of their naive CD8 T cells and show a compensatory gain in absolute numbers of memory CD8 T cells.
In an accompanying manuscript (17) , we present results from a study of over 250 HIV-infected adults showing that, as in studies presented here for HIV-infected children, the naive CD8 subset is lost in parallel with total CD4 T cells. The studies presented here were completed before our adult study was undertaken and provided one impetus for that study. Together, these two studies demonstrate that loss of the functionally important naive T cells from both CD4 and CD8 lineages is characteristic of HIV infection and thus suggest that the loss of these cells may play a major role in the immunopathogenesis of HIV disease.
Methods
Subjects. 12 HIV-infected children were recruited from the outpatient clinics at Children's Hospital Oakland (CHO)' and seven from Lucille Packard Children's Hospital (LPCH) at the Stanford University Medical Center. All HIV-infected children were receiving antiretroviral therapy (either AZT, DDI, or DDC, or some combination thereof). All children followed at CHO and two children at LPCH were receiving monthly intravenous immunoglobulin therapy.
The children who served as HIV-negative controls were recruited from the Pediatric Endocrinology Clinic at LPCH. All children accepted into the study had no risk factors for HIV infection. The HIV-negative controls either were considered healthy and in no need of therapy or were isolated growth hormone or isolated thyroid hormone deficient and were being treated with replacement therapy. Children were rejected from the study if they were receiving steroid therapy, had a history of cancer, had a CD4/CD8 ratio of < 1, or were not growing parallel to the normal growth curve.
All participants in this study were recruited for our investigation of glutathione levels in plasma, red blood cells, and peripheral blood mononuclear cell subsets in HIV-infected children. The result of the glutathione analyses will be reported elsewhere. All children were undergoing venipuncture for purposes relevant to their clinic visit. Informed consent was obtained; an additional 3 ml of blood was taken at the time of blood draw and placed in a heparinized tube. All participants had blood taken for a complete blood count, either from the aliquot taken for purposes of this study or because it was clinically indicated. Multiparameter FACS® analysis of CD8 T cells. Representative CD8 T cell subsets are shown in Fig. 1 . Flow cytometric analysis for three surface markers identifies a subset of cells which expresses low levels of CD1 la (CD1 laII) and high levels of CD45RA (CD45RAhi, Fig. 1, top row, solid arrows) . A similar analysis identifies a subset which is CD45RAhi and CD62Lhi (Fig. 1, bottom row, solid arrows) . This subset fits previous definitions of the naive subset of CD8 T cells (16, 20) . We have recently shown by four-color immunofluorescence analysis that all cells that fit the naive phenotype (CD11aIO, CD45RAhi) are also CD62Lhi (data not shown); however, not all CD1 laa cells are CD45RAhi. Thus, it is necessary to simultaneously measure three antigens (CD8, CD45RA, and CDl la or CD62L) to uniquely identify the naive cells.
In addition to the naive subset, Fig. 1 (left) shows three other subsets of CD8 T cells. For the purposes of this report, we refer to all of these subsets as memory cells because they are all CDIlahi (15) . These subsets of memory or effector cells further segregate on the basis of CD45RA and CD62L expression (Fig. 1, bottom row) . In general, the most frequent of these is the CD45RA-, CD62L-subset (Fig. 1, bottom row, hollow arrows); additional memory subsets express only CD62L or only CD45RA. Functional analysis of CD8 subsets. To confirm the previously identified functional differences between naive and memory CD8 subsets, we did three kinds of analyses on the naive and memory subsets: cytoplasmic calcium flux (a prerequisite event for proliferation, and the extent of the flux is related to proliferative capacity); proliferative response to several mitogenic stimuli, measured by DNA synthesis; and cytokine mRNA profiles in response to several stimuli, determined by reverse PCR. Fig. 2 A shows that the different subsets have substantially different capacities to transport calcium in response to the CD3 triggering. The naive cells respond very well, with a vigorous and sustained increase in cytoplasmic calcium. In contrast, the memory subsets show a much weaker flux. As expected, the ability to flux calcium is correlated with the subsequent mitogenic capacity of these cells (Table II) , i.e., the naive cells proliferated to a greater extent than the memory subsets. Finally, data from a limited survey of the cytokine profiles of the subsets (Fig. 2 B) are also consistent with the known phenotype of naive and memory cells. That is, the naive cells have a much more restricted cytokine profile, while only the memory subsets made the typical memory/effector cytokines IL-4, IL-5, or y-IFN.
Loss of naive CD8 and increase in memory CD8 T cells. Fig. 1 demonstrates that the majority of the CD8 T cells in HIV-negative control children are naive (middle, solid arrows). In contrast, the representative plots of HIV-infected children (Fig. 1, right) demonstrate a decrease of the naive subset and a commensurate increase of the memory subsets of CD8 T cells.
Summary data for all the children in the study are shown in Fig. 3 . In agreement with previous reports, the total CD8 T cell count (5, 6) and the frequency of the CD45RAhi, CD8 T cells (previously taken as the naive subset) do not differ significantly (7) (8) (9) between the HIV-infected and control children. In contrast, the naive subset as we define it (CD45RAh, CD1 la", CD62Lhi) is clearly decreased in HIV-infected children in absolute number (P c 0.003), as well as percentage of total CD8 T cells. While all memory subsets increased, the most significant increase was found for the CD45RA -CD62L -subset (P c 0.0004). The other memory subsets are also increased, although not to the same extent (HIV-infected versus HIV-negative controls, P < 0.05 for both subsets). Therefore, the increase in the total CD8 counts in HIV-infected children is due exclusively to an expansion of the memory subsets of CD8 T cells.
No differences were found for a variety of other variables. Within the group of HIV-infected children, we found no differences between those who acquired HIV horizontally or vertically or between those with or without AIDS (not shown). Similarly, among the HIV-negative controls, there were no differences between those who were or were not receiving growth hormone or L-thyroxine (not shown). In addition, we found no correlation between age and the number or percentage of naive CD8 T cells in either the HIV-negative or the HIV-infected children (not shown). Furthermore, we found no correlation between disease severity and either CD4 or CD8 counts.
The naive CD8 T cell count correlates with the total CD4 count in HIV-infected children. Fig. 4 shows that the HIVinfected children whose naive CD8 T cell counts are low also have low total CD4 counts. In essence, all but one of the HIVinfected children whose naive CD8 T cell counts fell below their median (186 cells/Il) have CD4 T cell counts that also fall below their median (526 cells//lI). Similarly, all but one of the HIV-infected children with high CD4 counts had high naive CD8 T cell counts. This correlation is significant by x2 analysis and Fisher's exact test (P . 0.001).
The specific clustering of CD4 counts and naive T cell counts in the HIV-infected children is also visible in a regression analysis of the data discussed above (see Fig. 4 ). For 
CD45RA+CD62L-1
IkT -! .- . Standard deviations were all < 15% of the mean. * The ratio of the proliferation signal for the naive cells to the proliferation signal for the memory population (background was subtracted from each value before division).
in HIV-infected children than in HIV-negative children (r2 for HIV-negative control, 0.38; for HIV-infected, 0.54). Total CD8 T cell counts, in contrast, show essentially no correlation with CD4 counts either in HIV-negative or in HIVinfected children. That is, there is no significant correlation of total CD4 and CD8 counts as measured by x2 analysis of HIVinfected children above and below the medians for CD4 and CD8 T cells ( (3, 21) . This encounter with antigen also triggers the naive T cell to differentiate and express the surface phenotype of memory cells (16) . Thereafter, when a memory T cell encounters its cognate antigen, the response is predominantly one of cytokine secretion rather than proliferation (3) . The definitions of naive and memory are based on studies published by others (15, 16) ; we confirmed these functional differences in the subsets defined here: the naive cells show a greater capacity to flux calcium and to proliferate in response to mitogenic stimuli, but have a more limited cytokine response than memory/ effector cells.
Our studies, which demonstrate that naive CD8 T cells decrease substantially in HIV-infected individuals, conflict with earlier observations indicating that naive CD8 T cell counts either decrease slightly or remain unchanged (8, 9, 11, (22) (23) (24) (28) and vitamin A-deficient children have increased CD45ROhi, CD8 T cells (29) . Similarly, chronic alcohol consumption by adults frequently results in a loss of T cell function and a concomitant decrease in the representation of naive T cell subsets (30) . But whether the decline in naive CD8 T cells is unique to HIV or occurs more generally in severe disease is irrelevant to the immunopathogenic consequences of the loss of these cells. Since naive T cells are crucial to immune responsiveness, their loss may have as severe an impact in HIV disease as the overall loss of CD4 T cells.
In particular, HIV-infected children (and adults) with low CD4 T cell counts are more susceptible to infection with opportunistic organisms such as Pneumocystis carinji and Mycobacterium avium intracellulare. This immune deficiency has been ascribed to the decrease of CD4 T cells. However, our data show that the naive CD8 T cell count correlates with the total CD4 count. Thus, the immunodeficiency in HIV disease could be mediated either by low CD4 counts, low naive CD8 T cell counts, or, most likely, a combination of both in conjunction with other factors.
In conclusion, we have demonstrated a clear loss of the naive subset of CD8 T cells and an increase in CD8 memory T cells in HIV-infected children. In an accompanying manuscript, we show that this loss also occurs in adults (17) and that it is similarly correlated with the loss of total CD4 cells. We suggest that these changes may contribute to the increased susceptibility to infection and the loss of cell-mediated immunity that is observed in HIV-infected individuals. In addition, because naive T cells are so important for the generation of new immune responses, we suggest that the naive counts be used to stratify clinical trials of therapeutic vaccinations and immunomodulatory therapies in HIV disease.
